Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry

Clicks: 14
ID: 332429
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #149 of 209 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 209 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims Advanced chronic kidney disease (CKD) confers a very high cardiovascular disease (CVD) risk, requiring comprehensive risk factor assessment. However, real-world data on current practices in patients with cardiorenal disease remain limited. We aimed to evaluate the control of cardiovascular risk factors, with a focus on lipid management, in a contemporary cardiorenal cohort. Methods This cross-sectional analysis was conducted within the Cardioren Registry, which enrolled patients with chronic heart failure from 13 tertiary hospitals in Spain (2021–2022). Of 1,107 patients, 885 with complete data on LDL-C, albuminuria, and atherosclerotic cardiovascular disease (ASCVD) were eligible. The present analysis was restricted to the patients who met the definition of advanced CKD, defined as eGFR <30 mL/min/1.73 m² or eGFR 30–45 mL/min/1.73 m² with albuminuria >30 mg/g. ASCVD was defined as prior ischemic heart disease, stroke, or peripheral arterial disease. The proportion of patients with LDL-C <55 mg/dL was assessed. Multivariable logistic regression models, including a parsimonious primary model and sensitivity analyses, were used to identify factors associated with lower LDL-C levels. Results Advanced CKD was present in 221 patients (25%); median age was 79 years, 58.8% were male, and 52.9% had ASCVD. Median LDL-C was 73 mg/dL, and only 22.6% achieved a LDL-C below 55 mg/dL. Achievement of LDL-C <55 mg/dL was significantly lower in patients without ASCVD compared with those with ASCVD (13.4% vs. 30.7%; p=0.002). In multivariable analysis, ASCVD was independently associated with a higher likelihood of achieving LDL-C <55 mg/dL, whereas female sex was independently associated with a lower likelihood of achieving this level. Conclusions In patients with advanced CKD, lipid control was below cardiology guideline recommendations for patients at very high cardiovascular disease risk, particularly among those without ASCVD and in women.
Reference Key
openalex_W7222063623 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ramón Garrido González, Almudena Castro, Rafael de la Espriella, Jara Gayán Ordás, Isabel Zegrí‐Reiriz, Pau Llàcer, Aleix Fort, Adriana Rodríguez Chavarri, Ana Méndez, Zorba Blázquez‐Bermejo, Pedro Caravaca-Pérez, Jorge Rubio Gracia, Alejandro Recio Mayoral, José Manuel García Pinilla, Carlos Collado Macián, José Luis Górriz, María José Soler, Julio E. Núñez, Marta Cobo Marcos
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag369
URL
https://doi.org/10.1093/ckj/sfag369
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.